News | March 02, 2024
Cipla incorporates JV company in USA
Cipla completes transfer of Generics Business Undertaking
Cipla completes transfer of Generics Business Undertaking
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
The company has received Form 483 with three observations
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
InvaGen has received 5 inspectional observations in Form 483
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
Subscribe To Our Newsletter & Stay Updated
